SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential-Reference-Cited by-同舟云学术

SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential

Published:2013-01-18 Issue:2 Volume:34 Page:1107-1117
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Tian Yu-Feng,Chen Tzu-Ju,Lin Ching-Yih,Chen Li-Tzong,Lin Li-Ching,Hsing Chung-Hsi,Lee Sung-Wei,Sheu Ming-Jen,Lee Hao-Hsien,Shiue Yow-Ling,Huang Hsuan-Ying,Pan Hsin-Yi,Li Chien-Feng,Chen Shang-Hung

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-013-0652-z.pdf

Reference25 articles.

1. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–40.

2. Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006;24(28):4620–5.

3. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355(11):1114–23.

4. National Comprehensive Cancer Network Home Page. http://www.nccn.org/ . Accessed 10 Jan 2011.

5. Hyams DM, Mamounas EP, Petrelli N, Rockette H, Jones J, Wieand HS, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. Dis Colon Rectum. 1997;40(2):131–9.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway;Cancer Cell International;2024-02-10

2. Skp2: A critical molecule for ubiquitination and its role in cancer;Life Sciences;2024-02

3. Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets;Pharmaceutics;2021-12-21

4. Ubiquitination Regulators Discovered by Virtual Screening for the Treatment of Cancer;Frontiers in Cell and Developmental Biology;2021-05-12

5. Emerging Roles of SKP2 in Cancer Drug Resistance;Cells;2021-05-10